Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05465174
Title Nivolumab and DAY101 for Treatment of Craniopharyngioma in Children and Young Adults (PNOC029)
Acronym PNOC029
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sabine Mueller, MD, PhD
Indications
Therapies
Age Groups: adult | child
Covered Countries USA


No variant requirements are available.